Key takeaways
- Bacteriostatic Water for Injection, USP is sterile water with 0.9% (9 mg/mL) benzyl alcohol; Hospira also labels a 1.1% strength.
- Its US label is marked “Rx only”, and its one labelled use is diluting or dissolving other drugs on their maker’s instructions.
- Sterile water for injection has no preservative and comes only in single-dose containers whose unused portion is discarded.
- Sealed, it lasts until the printed expiry date; once opened, CDC guidance based on USP 797 sets a 28-day default unless the manufacturer states otherwise.
- An August 2026 FDA warning letter cited bacteriostatic water sold for “reconstituting” a seller’s research peptides as evidence the products were meant for people.
01What is bacteriostatic water?
Bacteriostatic Water for Injection, USP is sterile, nonpyrogenic water with benzyl alcohol added as a preservative. “USP” refers to its standard in the United States Pharmacopeia.
Hospira’s US label describes water for injection “containing 0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol added as a bacteriostatic preservative”, with a pH of 5.7 (range 4.5 to 7.0). The two strengths come in plastic and glass vials respectively.
“Bacteriostatic” names the preservative’s job: holding back bacterial growth in a container that will be entered more than once. The label calls it a “multiple-dose” container “from which repeated withdrawals may be made”. The preservative is not a sterilant. CDC notes that it “does not have an effect on viruses nor does it provide complete protection against bacterial contamination.”
The label gives it one job. It is “indicated only for diluting or dissolving drugs” for injection, “according to instructions of the manufacturer of the drug to be administered”. It is not a treatment in its own right: the UK product information for Pfizer’s bacteriostatic water lists its therapeutic indications as “None”.
02Bacteriostatic water vs sterile water vs saline: what’s the difference?
Of the four sterile diluents in the table, two are water and two are 0.9% sodium chloride (saline). Within each pair they differ in two ways: whether a preservative is present, and whether the container may be entered more than once. The wording below comes from Hospira’s US labels on DailyMed.
| Product | What is in it | Container | Label lines worth knowing |
|---|---|---|---|
| Bacteriostatic Water for Injection, USP | Water for injection with benzyl alcohol, 0.9% or 1.1% | “Multiple-dose” vial | “NOT FOR USE IN NEONATES” · “FOR DRUG DILUENT USE ONLY” · Rx only |
| Sterile Water for Injection, USP | Water for injection with “no bacteriostat, antimicrobial agent or added buffer” | “Single-dose” containers only | “Do not reuse single-dose containers. Discard unused portion.” · Rx only |
| Bacteriostatic 0.9% Sodium Chloride Injection, USP | Sodium chloride 9 mg/mL with benzyl alcohol 0.9%; isotonic | “Multiple-dose” vial | “NOT FOR USE IN NEONATES” · Rx only |
| 0.9% Sodium Chloride Injection, USP, preservative-free | Sodium chloride 9 mg/mL; “contains no preservatives”; isotonic | “Single-dose” containers only | “FOR USE AS A STERILE DILUENT” · discard unused portion · Rx only |
The diluents are not interchangeable. Each label defers to the maker of the drug being prepared, and each warns that some drugs “may be incompatible in a given vehicle”, including “a vehicle containing benzyl alcohol”.
03Why does the label say “not for use in neonates”?
The warning has a documented origin. On 11 June 1982, CDC’s Morbidity and Mortality Weekly Report described 16 deaths of pre-term newborns, reported to FDA by two medical centres, “thought to be caused by the benzyl alcohol preservative” in bacteriostatic saline used to flush their catheters. The illness included metabolic acidosis that progressed to “gasping respirations”. FDA recommended that flush solutions containing benzyl alcohol not be used for newborns.
Current labels carry that history. Hospira’s label says benzyl alcohol “has been associated with toxicity in neonates” and that solutions containing it “must not be used in this patient population”. The UK product information names the pattern “gasping syndrome” and adds that the preservative “may cause hypersensitivity reactions”.
04Is bacteriostatic water prescription-only?
United States. Yes. Hospira’s bacteriostatic water label is marked “Rx only”, and DailyMed lists it under an FDA new drug application, NDA 018802. The sterile water and both sodium chloride diluents in the table are also marked “Rx only”.
United Kingdom. The one bacteriostatic water on the electronic Medicines Compendium (emc) is Pfizer’s, licence PL 00057/0934, listed as a prescription-only medicine. It is a 1 mL pre-filled syringe supplied as the diluent for one alprostadil product, Caverject, and its product information lists no therapeutic indication.
Australia. We could not confirm its status; see what we don’t know, below.
05How long does bacteriostatic water last?
There are two clocks: the expiry date on a sealed vial, and a shorter limit once the vial has been opened.
Until the expiry date printed on the vial. Hospira’s vial label carries a lot number and an expiry date. The UK syringe product states a shelf life of 3 years.
Hospira’s label sets no in-use period of its own. CDC, citing USP General Chapter 797, says that once a multi-dose vial is opened or punctured it “should be dated and discarded within 28 days unless the manufacturer states another date for that opened vial”, and that this date “should never exceed the manufacturer’s original expiration date”. These are rules for healthcare settings.
The label says not to use it “unless the solution is clear and seal intact.”
Storage. The label’s storage is room temperature, not the fridge: Hospira says “Store at 20 to 25°C (68 to 77°F)”, and the UK product says store below 25 °C. That is the diluent’s own storage. Peptides follow different rules; see storing research peptides and lyophilised peptides, explained.
06Why does bacteriostatic water appear in FDA warning letters?
An August 2026 FDA warning letter cited bacteriostatic water sold for “reconstituting” a seller’s research peptides as part of the evidence that the products were meant for people.
In warning letters dated 24 August 2026, FDA wrote to online sellers of peptides labelled “research use only”. One letter said the seller marketed bacteriostatic water “as a solvent for reconstituting your products, thus, providing the means to prepare an injectable drug for human administration.” FDA treated that as part of the evidence that the products were intended for people.
This page describes the product and its label only. It contains no preparation steps and no amounts. Why there are no doses here explains the reasoning, and what “research use only” means covers the letters in full.
07What we don’t know
Australia. We could not confirm whether a bacteriostatic water product is included on the Australian Register of Therapeutic Goods, or how it is scheduled there.
Products sold outside pharmacy channels. We have seen no published testing of products sold online as “bacteriostatic water”, so we cannot say whether they match the labelled product described on this page.
A given product’s in-use limit. The 28-day figure is a default for healthcare settings. A manufacturer can set a different date, and only that product’s label can tell you which applies.
Plain-English summary of product labels and public guidance, checked on 18 Nov 2026. Not medical advice.